NYU's Holly Lofton and Harvard's Jennifer Manne-Goehler say trial safety looks similar to other GLP-1s, but warn gray market vials may hold no active drug.
Recap by typeshit. Full story at Women's Health.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
The comedian publicly thanked the GLP-1 drug Mounjaro for helping her drop 50 pounds. Parade has her comments.
The clinic reports more patients arriving on Ozempic, Wegovy or Mounjaro, and says the drugs' effects on the face now factor into surgical planning.
Loading…